Reaction
Glomerulosclerosis reporting signals
As of the last recalculation, Glomerulosclerosis appears in 624 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 111.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 37 | 111.5 | 111.8 |
| Ganciclovir | 27 | 91.9 | 92.2 |
| Ganciclovir Sodium | 27 | 88.9 | 89.1 |
| Valganciclovir Hydrochloride Powder, | 27 | 77.1 | 77.3 |
| Micafungin Sodium | 15 | 60.4 | 60.5 |
| Valganciclovir | 31 | 57.7 | 57.8 |
| Valganciclovir Hydrochloride | 31 | 57.7 | 57.8 |
| Sirolimus | 17 | 43.2 | 43.3 |
| Anti-Thymocyte Globulin (Rabbit) | 10 | 42.0 | 42.1 |
| Tacrolimus | 135 | 36.4 | 36.4 |
| Cefepime Hydrochloride | 16 | 34.0 | 34.0 |
| Tacrolimus Ointment 0.1% | 105 | 33.6 | 33.6 |
| Tacrolimus Extended-Release Capsules | 105 | 33.5 | 33.5 |
| Cefepime | 13 | 30.9 | 30.9 |
| Mycophenolic Acid | 28 | 30.5 | 30.5 |
| Clindamycin | 22 | 26.8 | 26.8 |
| Mycophenilic Acid | 15 | 24.7 | 24.7 |
| Tenofovir Disoproxil Fumarate Tablets | 6 | 23.4 | 23.4 |
| Bleomycin Sulfate | 7 | 22.8 | 22.9 |
| Ursosiol | 13 | 22.8 | 22.8 |
| Dolutegravir Sodium | 4 | 14.9 | 14.9 |